Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia

Metodi Balev; Victor Zibara; Grace Van Hyfte; Jonathan Feld; Marina Kremyanskaya; Michelle Becker; Alla Keyzner; Alan H. Shih; Bridget Marcellino; Hannah Levavi; Lewis Silverman; John Mascarenhas; Douglas Tremblay

doi:10.1002/ajh.27429

Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia

Metodi Balev, Victor Zibara, Grace Van Hyfte, Jonathan Feld, Marina Kremyanskaya, Michelle Becker, Alla Keyzner, Alan H. Shih, Bridget Marcellino, Hannah Levavi, Lewis Silverman, John Mascarenhas, Douglas Tremblay

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	American Journal of Hematology
DOIs	https://doi.org/10.1002/ajh.27429
State	Accepted/In press - 2024

Access to Document

10.1002/ajh.27429

Cite this

Balev, M., Zibara, V., Van Hyfte, G., Feld, J., Kremyanskaya, M., Becker, M., Keyzner, A., Shih, A. H., Marcellino, B., Levavi, H., Silverman, L., Mascarenhas, J., & Tremblay, D. (Accepted/In press). Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia. American Journal of Hematology. https://doi.org/10.1002/ajh.27429

@article{ba94938da8014d7d8c9d4063c13c9f9d,

title = "Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia",

author = "Metodi Balev and Victor Zibara and {Van Hyfte}, Grace and Jonathan Feld and Marina Kremyanskaya and Michelle Becker and Alla Keyzner and Shih, {Alan H.} and Bridget Marcellino and Hannah Levavi and Lewis Silverman and John Mascarenhas and Douglas Tremblay",

year = "2024",

doi = "10.1002/ajh.27429",

language = "English",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

}

Balev, M, Zibara, V, Van Hyfte, G, Feld, J, Kremyanskaya, M, Becker, M, Keyzner, A , Shih, AH , Marcellino, B, Levavi, H, Silverman, L , Mascarenhas, J & Tremblay, D 2024, 'Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia', American Journal of Hematology. https://doi.org/10.1002/ajh.27429

TY - JOUR

T1 - Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia

AU - Balev, Metodi

AU - Zibara, Victor

AU - Van Hyfte, Grace

AU - Feld, Jonathan

AU - Kremyanskaya, Marina

AU - Becker, Michelle

AU - Keyzner, Alla

AU - Shih, Alan H.

AU - Marcellino, Bridget

AU - Levavi, Hannah

AU - Silverman, Lewis

AU - Mascarenhas, John

AU - Tremblay, Douglas

PY - 2024

Y1 - 2024

UR - http://www.scopus.com/inward/record.url?scp=85197723710&partnerID=8YFLogxK

U2 - 10.1002/ajh.27429

DO - 10.1002/ajh.27429

M3 - Letter

AN - SCOPUS:85197723710

SN - 0361-8609

JO - American Journal of Hematology

JF - American Journal of Hematology

ER -